マーケットレポート詳細
3次元細胞培養の世界市場：製品別、エンドユーザー別2028年予測
3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年 7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文 237ページになります。
- 商品コード：MAM3330
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
3次元細胞培養の世界市場規模は2023年の13億ドルから2028年までに25億ドルへと拡大し、予測期間の市場の平均年成長率は14.6%で推移することが見込まれています。
レポートは3次元細胞培養の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、エンドユーザー別市場、等）を中心に構成されています。また競合状況、主要企業情報（15社）、市場ダイナミクス、バリューチェーン分析などの分析も加味し、3次元細胞培養市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆3次元細胞培養の世界市場予測2021-2028年
・市場規模(US$)
◆製品別、市場-2028年
スキャフォールド（足場）型3次元細胞培養
・ハイドロゲル/ECMアナログ
・天然/合成ハイドロゲル
・固体足場
・マイクロパターン表面
スキャフォールドフリー型3次元細胞培養
・低接着プレート
・ハンギングドロッププレート
・3次元バイオリアクター
・3次元ペトリ皿
マイクロ流体型3次元細胞培養
磁気/バイオプリント3次元細胞培養
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・製薬/バイオテクノロジー企業
・研究機関
・化粧品産業
・その他エンドユーザー
※(市場規模US$)
◆用途別、市場-2028年
・癌/幹細胞研究
・創薬/毒性試験
・組織工学/再生医療
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・業界構造分析（ファイブフォース分析）
・価格分析
・技術分析
・規制分析
・競合状況
・市場シェア分析
◆3次元細胞培養の主要企業プロフィール動向
・THERMO FISHER SCIENTIFIC, INC.
・MERCK KGAA
・CORNING INCORPORATED
・LONZA
・TECAN TRADING AG
・AVANTOR, INC.
・REPROCELL INC.
・3D BIOTEK LLC
・EMULATE, INC.
・SYNTHECON, INCORPORATED
・INSPHERO AG
・KIRKSTALL LTD.
・GREINER BIO-ONE INTERNATIONAL GMBH
・PROMOCELL GMBH
・UPM BIOMEDICALS
（その他企業）
・CN BIO INNOVATIONS LTD.
・TISSUSE GMBH
・LENA BIOSCIENCES INC.
・CELLENDES GMBH
・ADVANCED BIOMATRIX, INC. (PART OF BICO)
・SYNVIVO INC.
・AMSBIO
・MIMETAS BV
・S-BIO, VAUPELL HOLDINGS INC. (住友ベークライト株式会社のグループ企業)
・NANOFIBER SOLUTIONS
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 IMPACT OF ECONOMIC RECESSION ON 3D CELL CULTURE MARKET
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 2 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
・ FIGURE 3 3D CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2022
・ FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
・ FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
・ FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
・ FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
・ FIGURE 8 3D CELL CULTURE MARKET: CAGR PROJECTIONS, 2023–2028
・ FIGURE 9 3D CELL CULTURE MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON 3D CELL CULTURE MARKET
・ TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)
・ TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・ TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
・ FIGURE 11 3D CELL CULTURE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 3D CELL CULTURE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 3D CELL CULTURE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 GEOGRAPHICAL SNAPSHOT OF 3D CELL CULTURE MARKET
4 PREMIUM INSIGHTS
4.1 3D CELL CULTURE MARKET OVERVIEW
・ FIGURE 15 INCREASED FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO PROPEL MARKET
4.2 NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT AND COUNTRY (2022)
・ FIGURE 16 SCAFFOLD-BASED 3D CELL CULTURES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN 3D CELL CULTURE MARKET IN 2022
4.3 3D CELL CULTURE MARKET SHARE, BY APPLICATION, 2023 VS. 2028
・ FIGURE 17 CANCER & STEM CELL RESEARCH TO DOMINATE MARKET IN 2028
4.4 3D CELL CULTURE MARKET SHARE, BY END USER, 2022 (USD MILLION)
・ FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED 3D CELL CULTURE MARKET IN 2022
4.5 3D CELL CULTURE MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
・ FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 20 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 4 3D CELL CULTURE MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 HIGH FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING
5.2.1.2 GREATER ADOPTION OF PERSONALIZED MEDICINE GLOBALLY FOR MULTIPLE DISEASES
5.2.1.3 INCREASED GOVERNMENT SUPPORT AND FUNDING FOR 3D CELL CULTURE
5.2.1.4 INCREASED INDUSTRY-ACADEMIA COLLABORATION ON 3D CELL CULTURE AND RESEARCH
5.2.2 RESTRAINTS
5.2.2.1 HIGH COSTS OF IMPLEMENTING 3D CELL CULTURE TECHNOLOGIES
5.2.2.2 LACK OF WIDELY ACCEPTED OR SINGLE STANDARDIZATION IN 3D CELL CULTURE
5.2.3 OPPORTUNITIES
5.2.3.1 EMERGENCE OF MICROFLUIDICS-BASED 3D CELL CULTURE
5.2.3.2 HIGH GROWTH OPPORTUNITIES AND BOOMING BIOPHARMACEUTICAL SECTOR IN EMERGING ECONOMIES
5.2.4 CHALLENGES
5.2.4.1 LACK OF CONSISTENCY IN 3D CELL CULTURE PRODUCTS
5.2.4.2 HIGH DEPENDENCE ON PLASTIC WASTE DISPOSALS AND CONSUMABLES
・ TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
5.3 RANGES/SCENARIOS
・ FIGURE 21 SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF 3D CELL CULTURE MARKET
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 VALUE CHAIN ANALYSIS
・ FIGURE 22 VALUE CHAIN ANALYSIS OF 3D CELL CULTURE MARKET: RAW MATERIAL AND MANUFACTURING PHASE ADD MAXIMUM VALUE
5.6 SUPPLY CHAIN ANALYSIS
・ FIGURE 23 3D CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
・ FIGURE 24 ECOSYSTEM ANALYSIS: 3D CELL CULTURE MARKET
・ TABLE 6 3D CELL CULTURE MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 7 3D CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 PATENT ANALYSIS
5.9.1 LIST OF MAJOR PATENTS
5.10 PRICING ANALYSIS
・ TABLE 8 SELLING PRICE OF 3D CELL CULTURE PRODUCTS BY TOP PLAYERS (2022)
・ TABLE 9 AVERAGE SELLING PRICE, BY APPLICATION (2022)
5.11 TECHNOLOGY ANALYSIS
・ TABLE 10 ADVANTAGES AND DISADVANTAGES OF 3D CELL CULTURE TECHNIQUES
5.12 REGULATORY ANALYSIS
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 KEY CONFERENCES AND EVENTS IN 2023
・ TABLE 15 3D CELL CULTURE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF 3D CELL CULTURE PRODUCTS
5.14.2 BUYING CRITERIA
・ FIGURE 26 KEY BUYING CRITERIA FOR END USERS
6 3D CELL CULTURE MARKET, BY PRODUCT
6.1 INTRODUCTION
・ TABLE 16 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 SCAFFOLD-BASED 3D CELL CULTURES
・ TABLE 17 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 18 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 19 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 20 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 21 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 HYDROGELS/ECM ANALOGS
6.2.1.1 HYDROGELS/ECM ANALOGS TO DOMINATE SCAFFOLD-BASED 3D CELL CULTURES MARKET DURING FORECAST PERIOD
・ TABLE 22 HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 23 NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 24 EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 25 ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 NATURAL & SYNTHETIC HYDROGELS
6.2.2.1 EASY SYNTHETIZATION ON LARGE SCALE AND IMPROVED CONTROL OF MATRIX ARCHITECTURE TO PROPEL SEGMENT
・ TABLE 26 HYDROGELS/ECM ANALOGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.2.3 SOLID SCAFFOLDS 83
6.2.3.1 SOLID SCAFFOLDS TO BE WIDELY ADOPTED IN REGENERATIVE MEDICINE AND PRECLINICAL IN-VITRO TESTING
・ TABLE 27 SOLID SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 28 NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 29 EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 30 ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 MICROPATTERNED SURFACES
6.2.4.1 MICROPATTERNED SURFACES TO ENHANCE EXPRESSION OF ENZYME LEVELS AND DRUG REACTIVITY
・ TABLE 31 MICROPATTERNED SURFACES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 32 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 33 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 34 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SCAFFOLD-FREE 3D CELL CULTURES
・ TABLE 35 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 36 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 37 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 38 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 39 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 LOW ATTACHMENT PLATES
6.3.1.1 LOW ATTACHMENT PLATES TO GROW AT HIGHEST RATE IN SCAFFOLD-FREE 3D CELL CULTURES MARKET
・ TABLE 40 LOW ATTACHMENT PLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 41 NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 42 EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 43 ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 HANGING DROP PLATES
6.3.2.1 HANGING DROP PLATES TO BE MOSTLY USED IN STEM CELL DIFFERENTIATION AND CYTOTOXICITY RESEARCH
・ TABLE 44 HANGING DROP PLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 45 NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 46 EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 47 ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 3D BIOREACTORS
6.3.3.1 3D BIOREACTORS TO BE COMMONLY USED IN MASS PRODUCTION OF CELLS
・ TABLE 48 3D BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 49 NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 50 EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 51 ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.4 3D PETRI DISHES 98
6.3.4.1 EUROPE TO WITNESS HIGHEST GROWTH IN 3D PETRI DISHES DURING STUDY PERIOD
・ TABLE 52 3D PETRI DISHES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 53 NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 54 EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 55 ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 MICROFLUIDICS-BASED 3D CELL CULTURES
6.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
・ TABLE 56 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 57 NORTH AMERICA: 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 58 EUROPE: 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 59 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR 3D MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES
6.5.1 3D CELL CULTURE TO BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION
・ TABLE 60 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 61 NORTH AMERICA: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 62 EUROPE: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 63 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
7 3D CELL CULTURE MARKET, BY END USER
7.1 INTRODUCTION
・ TABLE 64 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS OF 3D CELL CULTURE PRODUCTS
・ TABLE 65 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 66 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 67 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 68 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 RESEARCH INSTITUTES
7.3.1 INCREASED GOVERNMENT FUNDING FOR RESEARCH AND HIGH PREVALENCE OF CANCER TO AUGMENT MARKET 108
・ TABLE 69 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 70 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 71 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 72 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 COSMETICS INDUSTRY
7.4.1 FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET
・ TABLE 73 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 74 NORTH AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 75 EUROPE: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 76 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 OTHER END USERS
・ TABLE 77 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 78 NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 79 EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 80 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
8 3D CELL CULTURE MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 81 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 CANCER & STEM CELL RESEARCH
8.2.1 RISING PREVALENCE OF CANCER AND OTHER COMPLEX DISEASES GLOBALLY TO PROPEL MARKET
・ TABLE 82 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 83 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 84 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 118
・ TABLE 85 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DRUG DISCOVERY & TOXICOLOGY TESTING
8.3.1 INCREASED ADOPTION OF PERSONALIZED MEDICINES AND EXPANSION OF PHARMACEUTICAL COMPANIES TO SUPPORT MARKET
・ TABLE 86 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2021–2028 (USD MILLION) 119
・ TABLE 87 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 88 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 89 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
8.4.1 INCREASING RESEARCH ON 3D CULTURE TECHNIQUES TO AID MARKET
・ TABLE 90 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 91 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 92 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 93 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
9 3D CELL CULTURE MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 94 3D CELL CULTURE MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
・ FIGURE 27 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
・ TABLE 95 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 96 NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 97 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 98 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 99 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 100 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 ADOPTION OF INNOVATIVE TECHNIQUES AND GOVERNMENT-FUNDED INITIATIVES TO DRIVE MARKET
・ TABLE 101 US: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 102 US: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 103 US: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 104 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 105 US: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 ADVANCEMENTS IN REGENERATIVE MEDICINE TO BOOST MARKET
・ TABLE 106 CANADA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 107 CANADA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 108 CANADA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 109 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 110 CANADA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
・ TABLE 111 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 112 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 113 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 114 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 115 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 116 EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 SPIKE IN INVESTMENTS BY KEY PLAYERS AND GROWING FUNDING FROM GOVERNMENT ORGANIZATIONS TO FUEL MARKET
・ TABLE 117 GERMANY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 118 GERMANY: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 119 GERMANY: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 120 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 121 GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 GROWTH IN LIFE SCIENCES INDUSTRY TO DRIVE MARKET
・ TABLE 122 UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 123 UK: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 124 UK: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 125 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 126 UK: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 GROWTH IN BIOTECHNOLOGY INDUSTRY TO PROPEL MARKET
・ TABLE 127 FRANCE: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 128 FRANCE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 129 FRANCE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 130 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 131 FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 INCREASE IN RESEARCH ACTIVITIES AND FUNDS TO BOOST MARKET
・ TABLE 132 ITALY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 133 ITALY: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 134 ITALY: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 135 ITALY: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 136 ITALY: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 INCREASED COLLABORATIONS IN RESEARCH AND FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET
・ TABLE 137 SPAIN: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 138 SPAIN: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 139 SPAIN: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 140 SPAIN: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 141 SPAIN: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 REST OF EUROPE
・ TABLE 142 REST OF EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 143 REST OF EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 144 REST OF EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 145 REST OF EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 146 REST OF EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
・ FIGURE 28 ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT
・ TABLE 147 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 148 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 149 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 150 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 151 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 152 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 CHINA
9.4.1.1 GOVERNMENT SUPPORT AND STRATEGIC INITIATIVES BY KEY PLAYERS TO STRENGTHEN USE OF BIOTECHNOLOGY
・ TABLE 153 CHINA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 154 CHINA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 155 CHINA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 156 CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 157 CHINA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 RISING PREVALENCE OF CANCER AND INCREASED ADOPTION OF 3D CELL CULTURE TO AUGMENT MARKET GROWTH
・ TABLE 158 JAPAN: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 159 JAPAN: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 160 JAPAN: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 161 JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 162 JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 GROWTH IN LIFE SCIENCES INDUSTRY TO SUPPORT MARKET
・ TABLE 163 INDIA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 164 INDIA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 165 INDIA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 166 INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 167 INDIA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
・ TABLE 168 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
9.4.5 ASIA PACIFIC: RECESSION IMPACT
・ TABLE 169 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 170 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 171 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 172 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 GROWING GOVERNMENT INVESTMENTS AND AVAILABILITY OF GRANTS FOR CELL-BASED RESEARCH TO DRIVE MARKET
・ TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 174 LATIN AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 175 LATIN AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 176 LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 177 LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASED FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN RESEARCH TO AID MARKET
・ TABLE 178 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 179 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 180 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 181 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 182 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
・ FIGURE 29 3D CELL CULTURE MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE SHARE ANALYSIS
・ FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
10.4 MARKET SHARE ANALYSIS
・ FIGURE 31 3D CELL CULTURE MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
・ TABLE 183 3D CELL CULTURE MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
・ FIGURE 32 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
・ TABLE 184 3D CELL CULTURE MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
・ TABLE 185 3D CELL CULTURE MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.7.1 PROGRESSIVE COMPANIES
10.7.2 STARTING BLOCKS
10.7.3 RESPONSIVE COMPANIES
10.7.4 DYNAMIC COMPANIES
・ FIGURE 33 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
・ TABLE 186 3D CELL CULTURE MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
・ TABLE 187 3D CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
10.9 COMPETITIVE SCENARIOS AND TRENDS
10.9.1 PRODUCT LAUNCHES
・ TABLE 188 3D CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023
10.9.2 DEALS
・ TABLE 189 3D CELL CULTURE MARKET: DEALS, JANUARY 2020–APRIL 2023
10.9.3 OTHER DEVELOPMENTS
・ TABLE 190 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS 195
(BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS)*
11.1.1 THERMO FISHER SCIENTIFIC, INC.
・ TABLE 191 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
・ FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
11.1.2 MERCK KGAA
・ TABLE 192 MERCK KGAA: COMPANY OVERVIEW 199
・ FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.3 CORNING INCORPORATED
・ TABLE 193 CORNING INCORPORATED: COMPANY OVERVIEW
・ FIGURE 36 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
11.1.4 LONZA
・ TABLE 194 LONZA: COMPANY OVERVIEW
・ FIGURE 37 LONZA: COMPANY SNAPSHOT (2022)
11.1.5 TECAN TRADING AG
・ TABLE 195 TECAN TRADING AG: COMPANY OVERVIEW
・ FIGURE 38 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
11.1.6 AVANTOR, INC.
・ TABLE 196 AVANTOR, INC.: COMPANY OVERVIEW
・ FIGURE 39 AVANTOR, INC: COMPANY SNAPSHOT (2022)
11.1.7 REPROCELL INC.
・ TABLE 197 REPROCELL: COMPANY OVERVIEW 214
11.1.8 3D BIOTEK LLC
・ TABLE 198 3D BIOTEK LLC: COMPANY OVERVIEW
11.1.9 EMULATE, INC.
・ TABLE 199 EMULATE, INC.: COMPANY OVERVIEW
11.1.10 SYNTHECON, INCORPORATED
・ TABLE 200 SYNTHECON, INCORPORATED: COMPANY OVERVIEW
11.1.11 INSPHERO AG
・ TABLE 201 INSPHERO AG: COMPANY OVERVIEW
11.1.12 KIRKSTALL LTD.
・ TABLE 202 KIRKSTALL LTD.: COMPANY OVERVIEW
11.1.13 GREINER BIO-ONE INTERNATIONAL GMBH
・ TABLE 203 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW
11.1.14 PROMOCELL GMBH
・ TABLE 204 PROMOCELL GMBH: COMPANY OVERVIEW
11.1.15 UPM BIOMEDICALS
・ TABLE 205 UPM: COMPANY OVERVIEW
*BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.2 OTHER PLAYERS
11.2.1 CN BIO INNOVATIONS LTD.
11.2.2 TISSUSE GMBH
11.2.3 LENA BIOSCIENCES INC.
11.2.4 CELLENDES GMBH
11.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO)
11.2.6 SYNVIVO INC.
11.2.7 AMSBIO
11.2.8 MIMETAS BV
11.2.9 S-BIO, VAUPELL HOLDINGS INC. (A GROUP COMPANY OF SUMITOMO BAKELITE CO., LTD.)
11.2.10 NANOFIBER SOLUTIONS